SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-07-041358
Filing Date
2007-02-28
Accepted
2007-02-27 20:16:06
Documents
4
Period of Report
2007-02-21
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 14206
2 PRESS RELEASE dex991.htm EX-99.1 368817
3 TRANSCRIPT OF WEBCAST CONFERENCE CALL dex992.htm EX-99.2 92859
4 GRAPHIC g11235image001.jpg GRAPHIC 18645
  Complete submission text file 0001193125-07-041358.txt   503327
Mailing Address 34801 CAMPUS DR FREMONT CA 94555
Business Address 34801 CAMPUS DR FREMONT CA 94555 5105741400
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19756 | Film No.: 07654935
SIC: 2836 Biological Products, (No Diagnostic Substances)